Jinhe Biotechnology Co., Ltd

Jinhe Biotechnology Co., Ltd. is a private holding enterprise mainly producing and selling feeding chlortetracycline and animal health products. In 1998, it was recognized as "national key high-tech enterprise" by the State Science and Technology Commission, and it is also one of the 60 key enterprises in Inner Mongolia Autonomous Region.

The company is located in Tuoketuo County, Inner Mongolia, on the south foot of Qingshan mountain and the Bank of the Yellow River. It is adjacent to Datang Tuoketuo Power Plant, the largest thermal power plant in Asia, and faces Zhungeer coalfield, the largest open-pit coal mine in China, across the Yellow River. It has unique geographical advantages and resource advantages.

The company now has international advanced fermentation production equipment and product quality detection equipment. The main process is all controlled by computer automatically. The existing tonnage of fermentation is 5794 cubic meters. The scale of chlortetracycline fermentation ranks the top in the world.

Its leading products "muxing" and "Jinhe" brand feed chlortetracycline have an annual production capacity of more than 53000 tons, and have successfully passed the quality acceptance of the US Federal Food and Drug Administration (FDA) for six consecutive times.

Products are mainly exported to the United States, Canada, Southeast Asia and other countries and regions, while the marketing network throughout the domestic provinces, cities (autonomous regions), market prospects are very broad.

As a high-tech enterprise, Jinhe Biotechnology Co., Ltd. has developed rapidly in recent years, which is mainly due to the people-oriented development idea and strong technical support.

Through the introduction of talents and the rational allocation of human resources, the enterprise has gradually formed its own talent echelon. While giving full play to the group effect of talent advantages, it has constantly improved and innovated in the field of production technology, which has laid a solid foundation for the sudden emergence of enterprises in the era of knowledge economy.

Good reputation and excellent quality come from the strict management and the tireless pursuit of technological innovation.

From 2001 to 2002, the company successfully passed the ISO9002 quality system certification and GMP acceptance of national veterinary drug enterprises.

Since 1994, the company has successfully passed the quality acceptance of the Federal Food and Drug Administration (FDA) for six consecutive times, and has been recognized as a national key leading enterprise in agricultural industrialization by nine ministries and commissions.

In the future development process, Jinhe Biotechnology Co., Ltd. will follow the development concept of "facing the market, optimizing the structure, integrating resources and improving efficiency", take the fermentation industry as the carrier, take the adjustment of product structure as the main line, and take the road of combining extension and connotation to expand the recycling industry. Through alliance with industry elites, Jinhe Biotechnology Co., Ltd. will realize asset optimization and management upgrading, Combined with the exploration and research of high-tech means such as genetic engineering, the overall quality and core competitiveness of enterprises will be comprehensively improved, and the economic strength and development potential of enterprises will be further enhanced, so as to make new and greater contributions to the prosperity and development of national industry.